Keywords: Dydrogesterone; Myometrial contraction; Pregnancy; Progesterone receptor; RU486; Steroid;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Differential scanning calorimetry; Electron paramagnetic resonance; Fluorescence anisotropy; Fourier transform infrared spectroscopy; Human steroid hormones; Membrane; ANS; 1-anilino-8-naphthalene sulfonate; 12-AS; 12-(9-antroiloxy)-stearic acid; BDP; bec
Interaction of glucocorticoids and progesterone derivatives with human serum albumin
Keywords: Bil; Bilirubin; Co; cortisol; Cn; cortisone; DYG; dydrogesterone; 9-FA; 9-fluorocortisol acetate; FTIR; Fourier Transform Infrared Spectroscopy; GC; glucocorticoid; HSA; Human Serum Albumin; 17-OHPG; 17-hydroxyprogesterone; 21-OHPG; 21-hydroxyprogesterone
Keywords: Pregnancy; Recurrent spontaneous miscarriage; Progesterone; Dydrogesterone; Cytokines;
Keywords: Microfluidic chip; Two immiscible organic solvents; Levonorgestrel; Dydrogesterone; Medroxyprogesterone
Keywords: Dydrogesterone; Vaginal progesterone; Luteal phase support; IVF/ET; Pregnancy rate
Keywords: AD; Alzheimer's disease; ANOVA; analysis of variance; CEE; conjugated equine estrogen; DG; dydrogesterone; E2; 17β-estrogen; HRT; Hormone Replacement Therapy; MPA; medroxyprogesterone acetate; MWM; Morris water maze; OFT; open field test; OVX; ovariect
Keywords: Recurrent pregnancy loss; dydrogesterone; Th1 cytokines; Th2 cytokines; pregnancy outcome;
Keywords: Estradiol; Dydrogesterone; Efficacy; Safety; Metabolic parameters;
Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?
Keywords: Luteal phase support; progesterone; retroprogesterone; dydrogesterone; vaginal progesterone; progestogen;
The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage
Keywords: Threatened miscarriage; Serum progesterone; Micronised progesterone; Dydrogesterone; Randomised controlled trial;
Oral dydrogesterone for luteal support in frozen-thawed embryo transfer artificial cycles: A pilot randomized controlled trial
Keywords: Frozen-thawed embryo transfer; Luteal phase support; Dydrogesterone; Vaginal progesterone suppository; Intramuscular progesterone;
Activity of binary mixtures of drospirenone with progesterone and 17α-ethinylestradiol in vitro and in vivo
Keywords: DRS; drospirenone; P4; progesterone; MPA; medroxyprogesterone acetate; DDG; dydrogesterone; CA; concentration addition; AR; androgen receptor; ER; estrogen receptor; PR; progesterone receptor; MR; mineralocorticoid receptor; hpf; hours post fertilization;
Development of efficient SPE–TLC method and evaluation of biological interactions of contraceptives with progesterone receptors
Keywords: Norethindrone acetate; Dydrogesterone; TLC; SPE; Plasma; PyMOL; Autodoc4 softwares; Protein bindings
Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: Potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins
Keywords: 5α-DHT, 5α-dihydrotestosterone; 5α-DHP, 5α-dihydroprogesteroneProgesterone metabolism; Dydrogesterone; Progesterone; 20α-Hydroxysteroid dehydrogenase; 20α-Dihydrodydrogesterone; Medroxyprogesterone acetate
Dydrogesterone supplementation in women with threatened preterm delivery—the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor
Keywords: Progesterone-induced blocking factor; Dydrogesterone; Progesterone; Anti-inflammatory cytokines; Pro-inflammatory cytokines; Preterm delivery
Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3
Keywords: Dydrogesterone; 20α-Hydroxydydrogesterone; Progesterone; Medroxyprogesterone acetate; 20α-Hydroxyprogesterone; Aldo-keto reductase
Selectivity and potency of the retroprogesterone dydrogesterone in vitro
Keywords: Dydrogesterone; Steroid receptors; Pre-receptor metabolism; 17β-Hydroxysteroid dehydrogenase type 5 (AKR1C3); 17β-Hydroxysteroid dehydrogenase type 3; 5α-Reductase type 2
Ultra low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone: Protection of the endometrium and amenorrhoea rate
Keywords: Hormone replacement therapy; Endometrial safety; Bleeding; Estradiol; Dydrogesterone; Postmenopausal;
Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study
Keywords: Hormone replacement therapy; Oestradiol; Dydrogesterone; Postmenopausal; Vasomotor symptoms; Ultra-low dose
Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome
Keywords: Calcium plus vitamin D; Dydrogesterone; Premenstrual syndrome
Dydrogesterone in threatened miscarriage: A Malaysian experience
Keywords: Dydrogesterone; Malaysia; Pregnancy; Progestogen; Threatened miscarriage
Dydrogesterone support in threatened miscarriage
Keywords: Bleeding; Dydrogesterone; Pregnancy; Progestogen; Threatened miscarriage
Breast cancer and steroid metabolizing enzymes: The role of progestogens
Keywords: Breast cancer; Progestogen; Enzymes; Dydrogesterone; Progesterone
The place of dydrogesterone in the treatment of endometriosis and adenomyosis
Keywords: Endometriosis; Adenomyosis; Progestins; Dydrogesterone; Bleeding disorders
Short-term effects of two continuous combined oestrogen–progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: A randomised controlled trial
Keywords: C-reactive protein; Dydrogesterone; Fibrinolysis; Haemostasis; Homocysteine; Medroxyprogesteroneacetate; Menopause; Oestrogen
Luteal support: Progestogens for pregnancy protection
Keywords: Luteal support; Pregnancy; Progesterone; Progestogen; Dydrogesterone; Miscarriage
Treatment options for threatened miscarriage
Keywords: Threatened miscarriage; Vaginal bleeding; Pregnancy; Progesterone; Dydrogesterone
Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium
Keywords: Dydrogesterone; Progestational effect; Progesterone; Hormone replacement therapy; Endometrium
Use of dydrogesterone in hormone replacement therapy
Keywords: Hormone replacement therapy; Breast cancer; Cardiovascular; Dydrogesterone; Progestogen
Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats
Keywords: Dydrogesterone; allopregnanolone; beta-endorphin; central nervous system; rats
Low-dose hormone therapy in the perimenopause
Keywords: Perimenopause; Low-dose hormone therapy; Bleeding pattern; Vasomotor symptom; Hot flushes; Dydrogesterone
Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone
Keywords: Threatened abortion; Doppler; progesterone; dydrogesterone
Continuous combined hormone replacement therapy with 1 mg 17β-oestradiol and 5 mg dydrogesterone (Femoston®-conti): Endometrial safety and bleeding profile
Keywords: Hormone replacement therapy; Low dose; Continuous; Combined; 17β-Oestradiol; Dydrogesterone; Uterine bleeding; Endometrial safety
A comparative molecular modeling study of dydrogesterone with other progestational agents through theoretical calculations and nuclear magnetic resonance spectroscopy
Keywords: Dydrogesterone; Progestins; Retrosteroids; Molecular modeling; DFT calculations; NMR
Effects of dydrogesterone and of its stable metabolite, 20-α-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells
Keywords: Cardiovascular disease; endothelial cells; progestins; dydrogesterone; 20-α-dihydrodydrogesterone; nitric oxide
Dydrogesterone in the reduction of recurrent spontaneous abortion
Keywords: Spontaneous abortion; Recurrent abortion; Progesterone; Dydrogesterone; Human chorionic gonadotrophin; Pregnancy;
Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: Results of a randomised study
Keywords: In-vitro fertilisation; Luteal support; Micronised progesterone; Dydrogesterone; Assisted reproductive technology;
Dydrogesterone in threatened abortion: Pregnancy outcome
Keywords: Dydrogesterone; Threatened abortion; Pregnancy; Luteal support;
The role of dydrogesterone in recurrent (habitual) abortion
Keywords: Dydrogesterone; Recurrent abortion; Miscarriage; Progesterone-induced blocking factor;